The groundbreaking treatment of tirzepatide peptide represents a major advance in the handling of the condition. Unlike existing drugs, tirzepatide targets two pathways – GLP-1 and the GIP hormone – providing greater blood sugar management and anticipated weight loss. Experts are exploring its long-term effects and role in the complete treatmen